You just read:

MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies

News provided by

MEI Pharma, Inc.

Oct 11, 2018, 06:00 ET